» Articles » PMID: 14555911

Defining Complex Contributions of NOD2/CARD15 Gene Mutations, Age at Onset, and Tobacco Use on Crohn's Disease Phenotypes

Abstract

Background: Multiple factors, particularly IBD family history, tobacco use, age at diagnosis and recently, NOD2 mutant genotypes may influence Crohn's disease (CD) heterogeneity.

Methods: We performed a multicenter retrospective record analysis of 275 unrelated patients with CD. Age at diagnosis, IBD family history, Jewish ethnicity, tobacco use at diagnosis, surgical history, disease site and clinical behavior were correlated with genotypes for NOD2 mutations, and all risk factors were assessed for independent influence on outcomes of disease site, behavior and surgery free survival.

Results: Risk of ileal disease was increased for CD patients with two NOD2 mutations (Odds Ratio, O.R. 10.1), a smoking history (O.R. 2.25 per pack per day at diagnosis) or a younger age at diagnosis (O.R. 0.97 per each increased year). Presence of ileal disease (O.R. 4.8) and carrying one or two NOD2 mutations (O.R. 1.9 and 3.5, respectively) were independent risk factors for stricturing or non-perianal fistulizing behavior. Ileal disease, youthful onset and smoking at diagnosis (but not NOD2 mutations) were risk factors for early surgery.

Conclusions: Carrying two NOD2 mutations predicts youthful onset, ileal disease involvement, and development of stricturing or non-perianal fistulizing complications. Smoking and early onset independently influence ileal site and time to surgery.

Citing Articles

Single cell sequencing data identify distinct B cell and fibroblast populations in stricturing Crohn's disease.

Humphreys D, Lewis A, Pan-Castillo B, Berti G, Mein C, Wozniak E J Cell Mol Med. 2024; 28(9):e18344.

PMID: 38685679 PMC: 11058334. DOI: 10.1111/jcmm.18344.


Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease.

Sosna B, Aebisher D, Mysliwiec A, Dynarowicz K, Bartusik-Aebisher D, Oles P Int J Mol Sci. 2024; 25(1).

PMID: 38203373 PMC: 10779120. DOI: 10.3390/ijms25010202.


A Logistic Regression Model for Predicting the Risk of Subsequent Surgery among Patients with Newly Diagnosed Crohn's Disease Using a Brute Force Method.

Ogasawara K, Hiraga H, Sasaki Y, Hiraga N, Higuchi N, Hasui K Diagnostics (Basel). 2023; 13(23).

PMID: 38066829 PMC: 10706147. DOI: 10.3390/diagnostics13233587.


The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn's Disease With Poor Prognostic Factors: The MODIFY Study.

Mantzaris G, Zeglinas C, Theodoropoulou A, Koutroubakis I, Orfanoudaki E, Katsanos K Crohns Colitis 360. 2023; 3(4):otab064.

PMID: 36777275 PMC: 9802300. DOI: 10.1093/crocol/otab064.


The genetics of non-monogenic IBD.

Jans D, Cleynen I Hum Genet. 2023; 142(5):669-682.

PMID: 36720734 DOI: 10.1007/s00439-023-02521-9.